Loxo: 3Q Earnings Snapshot

November 8, 2018

STAMFORD, Conn. (AP) _ Loxo Oncology Inc. (LOXO) on Thursday reported a loss of $27.1 million in its third quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 89 cents. Losses, adjusted for non-recurring gains, were $2.26 per share.

The developer of cancer treatments posted revenue of $42.5 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $43.1 million.

Loxo shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LOXO at https://www.zacks.com/ap/LOXO

Update hourly